| GTO ID | GTC0793 |
| Trial ID | ChiCTR1900022291 |
| Disease | B-Cell Lymphoma |
| Therapy | CAR-T cell |
| Treatment | MBC19 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Phase 1 single-Center Study for Evaluating the Safety, Efficacy and Pharmacokinetic Characteristics of MBC19 in Subjects with relapsed or refractory B-cell lymphoma |
| Year | 2019 |
| Country | China |
| Company sponsor | West China Hospital, Sichuan University |
| Cohort 1 | |||||||||
|
|||||||||